Ohio State, Ohio University pool resources to address start-up funding

Brutus Buckeye and Rufus the Bobcat did not attend the announcement

The Ohio State University and Ohio University are partnering to create a new commercialization and funding model. They have committed $35 million in total to the formation of a venture capital fund designed to meet early-stage funding needs of innovative technology ventures.

Ohio State’s commitment to the fund is $20 million and Ohio University has pledged $15 million. The universities also will leverage their resources and assets to bring the best talent, funding and facilities to accelerate entrepreneurial activity and venture creation in Ohio.

“Universities, with our depth of research expertise, creative faculty, business capabilities and eager, well-prepared students, are uniquely positioned to help innovative companies grow and succeed,” said Ohio State President E. Gordon Gee. “We are honored to be partnering with Ohio University to enhance the state’s commercialization ecosystem, building a stronger environment in which to grow our economy.”

“We believe we have identified a new model for technology commercialization success,” said Ohio University President Roderick J. McDavis. “Taking what we have learned on an institutional level and applying it on a larger scale has great potential for our state, our students, faculty, staff, and most importantly, all Ohioans.”

Both institutions are BioOhio Founding Members and boast world-class biomedical research capabilities. It is safe to assume medical and health-related innovations will garner significant attention from the newly created fund.

Get more details in news releases from OSU and OU.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

CWRU summer biomedical program, in 13th year, transforms high school students into scientists | Cleveland.com, July 28, 2014

Cleveland helping to power a growing Midwest bioscience industry, study shows | Cleveland.com, July 28, 2014

ChanTest announces newly validated and re-engineered cells, expands portfolio of ion channel and GPCR cell lines | PR Web, July 24, 2014

Alkermes announces initiation of phase 1 clinical study of ALKS 8700 for treatment of multiple sclerosis | Business Wire, July 17, 2014

National Psoriasis Foundation awards grants to two Case Western Reserve University researchers | Science Codex, July 16, 2014

HIV test developed at University Hospitals to be distributed nationally by Utah-based company | Cleveland.com, July 16, 2014

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine | News Medical.net, July 16, 2014

Dayton Children’s Hosptial adds Dr. Aranda, bringing new advanced techniques in minimally invasive surgery | Xenia Gazette, July 16, 2014

3Bar Biologics takes cutting-edge technology out to corn fields | Akron Legal News, July 15, 2014

University of Cincinnati report shows need for better data on Ohio’s healthcare workforce | UC Health News, July 15, 2014

McNees recognized as one of the nation’s most-favored IP boutiques | McNees Wallace & Nurick, July 11, 2014

The Wright State University and Premier Health Neuroscience Institute has added Dayton Children’s to its research program | Dayton Business Journal, July 10, 2014

Sparton acquires Electronic Manufacturing Technology, LLC of Irvine, CA | Sparton, July 10, 2014

Cleveland Clinic collaborates Parker Hannifin to develop advanced medical technologies | PR Newswire, July 10, 2014

Austen BioInnovation Institute in Akron gets nearly $5 million in support | Akron Beacon Journal, July 9, 2014

Alkermes announces notices of allowance for U.S. patents for four CNS pipeline candidates | Business Wire, July 9, 2014

Students from Bethel-Tate High School gain valuable biotech job skills with Grant Career Center | WCPO9 Cincinnati, July 8, 2014

Rocket Ventures, the Regional Growth Partnership’s venture capital fund, is restarting its TechConnect networking events | Toledo Blade, July 8, 2014

NanoLogix news: Exhibiting at the Ohio Bioscience Expo and Showcase, receives European patent, working with NASA and Ohio Representative Tim Ryan | BusinessWire, July 8, 2014

CTI Clinical Trial and Consulting Services continues growth, adds seven and promotes three | Cincinnati.com, July 7, 2014